Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
78.65    -1.40 (-1.75%)
Bid:
79.05
Ask:
79.70
Spread: 0.65 (0.822%)
Market Cap: £1.51b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

UK pension scheme update

6 Dec 2022 07:00

RNS Number : 6730I
Coats Group PLC
06 December 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU NO. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

 

6 December 2022

Coats Group plc

A major step forward with partial buy-in of UK defined benefit pension scheme

Coats Group plc ("Coats" or the "Group") is pleased to announce that the trustee of the Coats UK Pension Scheme ("the scheme") has purchased a c£350m bulk annuity policy from Aviva which insures benefits payable under the scheme in respect of c3,700 pensioner and dependant members. These members represent roughly 20% of the scheme's liabilities.

The purchase of this policy sees all the scheme's financial and demographic risks fully hedged for the covered liabilities. The scheme will receive a regular stream of income that matches the pension payments for the covered members, making it a precise liability hedging asset, thus further de-risking the scheme and reducing future balance sheet volatility. This builds on the significant positive steps to de-risk the scheme in recent years through which 90% of the scheme's inflation / interest rate exposure had previously been hedged.

The Aviva buy-in is consistent with Coats' aspiration of fully insuring the scheme and removing it from the Group balance sheet. Once the scheme is fully funded and cash contributions cease, the Group's free cash generation will improve significantly allowing increased investment in growth or the return of excess capital to shareholders.

When the Technical Provisions deficit for the scheme was last formally assessed at 31 March 2021, as part of the triennial valuation cycle, it showed a £193m deficit. Updates since then indicate that the deficit had fallen closer to £55m by mid-November 2022, with a further reduction to £25m-£30m expected following the buy-in.

The Group will provide a further update at its 2022 full year results presentation in March 2023.

 

Conference call

The Group will host a call at 8am today covering this statement. Join the call by dialling +44 (0) 333 300 9035. A short presentation is also available on our website.

 

Jackie Callaway, Chief Financial Officer, said:

"The purchase of this bulk annuity policy represents an important step in further de-risking our UK defined benefit pension scheme. It moves us closer to eliminating our Technical Provisions deficit and achieving our ultimate plan of fully insuring, in a cost effective manner, the scheme and moving it off our balance sheet. Once the scheme is fully funded and cash contributions cease this will lead to a significant improvement in the Group's free cash generation. The completion of the buy-in reflects the constructive and collaborative working relationship between the Group and the trustee and I would like to thank all involved for helping us get to this position, which will benefit all stakeholders."

 

 

Enquiry details

 

 

 

 

Investors

Chris Dyett

Coats Group plc

+44 (0)79 7497 4690

 

Media

Richard Mountain / Nick Hasell

FTI Consulting

+44 (0)20 3727 1374

 

 

Notes

1. The Coats UK Pension Scheme is Coats Group plc's sole defined benefit pension scheme in the UK, having been formed from the merger of three legacy pension schemes in 2018.

2. The policy, commonly termed a pensioner "buy-in", is underwritten by Aviva Life and Pensions UK Limited, a leading UK life insurance business specialising in bulk annuity contracts.

3. Aviva was selected by the scheme trustee following a competitive selection process overseen by a joint working group established between Coats and the trustee.

 

About Coats Group plc

Coats is a world leader in thread manufacturing and structural components for apparel and footwear, as well as an innovative pioneer in performance materials. These critical solutions are used to create a wide range of products, including ones that provide safety and protection for people, data and the environment. Headquartered in the UK, Coats is a FTSE250 company and a FTSE4Good Index constituent. Revenues in 2021 were $1.8bn.

Trusted by the world's leading companies to deliver crucial, innovative, and sustainable solutions, Coats provides value-adding products including apparel, accessory and footwear threads, structural footwear components, fabrics, yarns and software applications. Customer partners include companies from the apparel, footwear, automotive, telecoms, personal protection, and outdoor goods industries.

With a proud heritage dating back more than 250 years and spirit of evolution to constantly stay ahead of changing market needs, Coats has operations across some 50 countries with a workforce of over 17,000, serving its customers worldwide. 

Coats connects talent, textiles, and technology, to make a better and more sustainable world. Worldwide, there are three dedicated Coats Innovation Hubs, where experts collaborate with partners to create the materials and products of tomorrow. It participates in the UN Global Compact and is committed to Science Based sustainability targets for 2030 and beyond, with a goal of achieving net-zero by 2050. Coats is also committed to achieving its goals in Diversity, Equity & Inclusion, workplace health & safety, employee & community wellbeing, and supplier social performance.

To find out more about Coats visit www.coats.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAEASEEKAFAA
Date   Source Headline
8th Jun 20269:23 amRNSHolding(s) in Company
20th May 20264:16 pmRNSResult of AGM
20th May 20267:00 amRNSTrading Statement
14th May 202611:00 amRNSAppointment of Chair
6th May 202611:00 amRNSDirectorate change
24th Apr 20261:15 pmRNSHolding(s) in Company
8th Apr 202611:00 amRNSDirector Declaration
30th Mar 202611:15 amRNSDirector/PDMR Shareholding
24th Mar 202611:08 amRNSHolding(s) in Company
17th Mar 20262:07 pmRNSDirector/PDMR Shareholding
12th Mar 202610:03 amRNSAnnual Financial Report
12th Mar 202610:03 amRNSAnnual Financial Report
5th Mar 20267:00 amRNS2025 Full Year Results
11th Feb 202611:00 amRNSChanges to Director's Responsibilities
9th Feb 20262:07 pmRNSHolding(s) in Company
6th Feb 20262:00 pmRNSDirector Declaration
17th Dec 20252:00 pmRNSDirector/PDMR Shareholding
7th Nov 20257:00 amRNSTrading Statement
5th Nov 20252:45 pmRNSDirector Declaration
30th Oct 20257:00 amRNSCompletion of OrthoLite acquisition
20th Oct 202512:41 pmRNSDirector/PDMR Shareholding
17th Oct 20251:42 pmRNSHolding(s) in Company
6th Oct 20251:06 pmRNSBlock listing Interim Review
16th Sep 20252:00 pmRNSDirector Declaration
12th Sep 20253:22 pmRNSHolding(s) in Company
11th Sep 20253:13 pmRNSHolding(s) in Company
10th Sep 20251:09 pmRNSDirector/PDMR Shareholding
3rd Sep 202512:58 pmRNSHolding(s) in Company
11th Aug 202511:03 amRNSHolding(s) in Company
5th Aug 202510:44 amRNSHolding(s) in Company
31st Jul 202512:39 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSFurther Information re Acquisition of OrthoLite
23rd Jul 20259:26 amRNSHolding(s) in Company
22nd Jul 202510:31 amRNSHolding(s) in Company
21st Jul 20253:25 pmRNSDirector/PDMR Shareholding
21st Jul 20252:30 pmRNSHolding(s) in Company
21st Jul 20252:27 pmRNSHolding(s) in Company
17th Jul 20256:00 pmRNSCoats Group
17th Jul 20257:00 amRNSResults of Capital Raise
16th Jul 20255:47 pmRNSAcquisition - Retail Offer Launch (Replacement)
16th Jul 20254:50 pmRNSAcquisition - Retail Offer Launch
16th Jul 20254:46 pmRNSAcquisition - Capital Raise Launch
16th Jul 20254:45 pmRNSHalf-year Report
16th Jul 20254:45 pmRNSAcquisition
27th Jun 20251:06 pmRNSHolding(s) in Company
24th Jun 20257:00 amRNSDirectorate Change
4th Jun 20251:42 pmRNSDirector/PDMR Shareholding
23rd May 202511:32 amRNSDirector/PDMR Shareholding
21st May 20253:58 pmRNSResult of AGM
21st May 20257:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.